Evidence map›Paper›PMID 40860805›Full record

ArticleFrontiers in oncology2025

Dedifferentiated adamantinoma of long bones: a case report and literature review.

Xiaofei Xiu, Jiajia Li, Lisha Duan, Xiaomei Wang, Zinan Guo, Xuelan Xiao, Qianhui Han, Feng Gao

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaofei XiuDepartment of Pathology, the Hebei Medical University Third Hospital, Hebei, Shijiazhuang, China.
Jiajia LiDepartment of Economics and Management, the Hebei Vocational College of Labour Relations, Hebei, Shijiazhuang, China.
Lisha DuanDepartment of Radiology, the Hebei Medical University Third Hospital, Hebei, Shijiazhuang, China.
Xiaomei WangDepartment of Pathology, the Hebei Medical University Third Hospital, Hebei, Shijiazhuang, China.
Zinan GuoDepartment of Pathology, the Hebei Medical University Third Hospital, Hebei, Shijiazhuang, China.
Xuelan XiaoDepartment of Pathology, the Hebei Medical University Third Hospital, Hebei, Shijiazhuang, China.
Qianhui HanDepartment of Pathology, the Hebei Medical University Third Hospital, Hebei, Shijiazhuang, China.
Feng GaoDepartment of Pathology, the Hebei Medical University Third Hospital, Hebei, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a rare case of dedifferentiated adamantinoma. The 48-year-old male patient was initially diagnosed with classic adamantinoma in the right fibula and underwent curettage. Two years postoperatively, the patient presented with progressive swelling and pain in the same region. Imaging disclosed an expansile lesion with mixed lytic and sclerotic changes involving the medulla and adjacent soft tissue. A biopsy was performed, and a diagnosis of classic adamantinoma was made. Considering the significant clinical symptoms and imaging features, a below-knee amputation was performed. Histologically, the tumor exhibited two distinct patterns: classic adamantinoma juxtaposed to a dedifferentiated component, characterized by chondrosarcomatous areas with moderate cellularity and abundant hyaline cartilage matrix. Myxoid areas containing malignant cartilage cells of myxoid chondrosarcoma were also observed. Immunohistochemically, the dedifferentiated areas showed complete loss of epithelial markers. At a two-year follow-up, the patient remains free of recurrence or metastasis. Dedifferentiated adamantinoma is an exceedingly rare primary bone tumor malignancy lacking specific clinical manifestations. In our case, the initial biopsy specimen revealed only epithelial cells, leading to an underdiagnosis of classic adamantinoma until further sampling revealed the dedifferentiated component. It underscores the importance of thorough sampling, close radiologic-pathologic correlation, and a multidisciplinary framework for accurate diagnosis and optimal management of complex bone tumors. Early recognition of the dedifferentiated features can guide appropriate surgical management and improve patient outcomes.

Indexed as

adamantinomabone neoplasmchondrosarcomadedifferentiatedprimary bone tumor

Identifiers

PMID40860805
PMCPMC12375482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.